AQR Arbitrage’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-22,100
Closed -$50K 1256
2021
Q2
$50K Buy
+22,100
New +$49.7K ﹤0.01% 948

Other funds holding ATIP.WS

AQR Arbitrage's ATIP.WS Position: Q3 2021 in Review

AQR Arbitrage sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q3 2021, closing a stake of 22,100 shares — an estimated $50K sold.

AQR Arbitrage first reported a position in ATIP.WS in Q2 2021 and held it in 1 quarter. The position peaked at $50K in Q2 2021. 20 funds tracked by Wall St. Rank hold ATIP.WS as of Q3 2021.

  • AQR Arbitrage reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q3 2021 after selling out during the quarter.
  • AQR Arbitrage sold 22,100 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q3 2021, an estimated $50K.
  • AQR Arbitrage first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 1 quarter.
  • AQR Arbitrage's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $50K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q3 2021.

Based on AQR Arbitrage's 13F filing for Q3 2021, filed 15 Nov 2021.